Keyword Suggestions

Results
 
 
Account Login
 
Username
 
 
 
Password
 
 
 
 
 

Library Navigation

 
 

Browse Conferences

 
 
 
40 Results Found, Showing 1 - 40
Sort By:
View:
Filter By:
Date/Time
Conference
Keyword
My Content
Start Date/Time:
End Date/Time:
 
Go
 
Conference
 
Keywords:
Click here to clear this filter
 
 
Go
Show only the content that I own
 
 
October 17, 2009 - Saturday
 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
24.94% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Total Credits:
0.50 CME  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SA11 - The Future of Oncology - Drugs in the Pipeline 
Relevancy:
24.94% 
 
Date/Time:
October 17, 2009   3:35pm - 4:10pm
 
Length:
43m 03s - 31 Slides  
 
Speaker:
Bruce A. Chabner, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 24, 2009 - Thursday
 
rating
HM101 - Treatment of Newly Diagnosed Myeloma in Non-transplant Candidates 
Relevancy:
80.68% 
 
Date/Time:
September 24, 2009   1:00pm - 1:30pm
 
Length:
18m 27s - 28 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Sagar Lonial, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM102 - Treatment of Newly Diagnosed Transplant Candidates 
Relevancy:
59.53% 
 
Date/Time:
September 24, 2009   1:35pm - 2:05pm
 
Length:
22m 40s - 32 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Muzzafar H. Qazilbash (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM103 - Treatment of Relapsed and Refractory Myeloma 
Relevancy:
100.00% 
 
Date/Time:
September 24, 2009   2:10pm - 2:40pm
 
Length:
22m 13s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Sagar Lonial, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM104 - Future Directions in Myeloma 
Relevancy:
58.17% 
 
Date/Time:
September 24, 2009   2:45pm - 3:15pm
 
Length:
40m 52s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Kenneth Anderson (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON104 - EBP Update 
Relevancy:
20.89% 
 
Date/Time:
September 24, 2009   2:45pm - 3:15pm
 
Length:
33m 08s - 33 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Dana N. Rutledge, RN, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
A107 - Germ Cell Tumors 
Relevancy:
21.02% 
 
Date/Time:
September 24, 2009   3:40pm - 4:00pm
 
Length:
27m 14s - 58 Slides  
 
Total Credits:
0.25 CME/CE  
 
Speaker:
Craig R. Nichols, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM106 - JAK2 Mutations in MPD: A Worthy Therapeutic Target? 
Relevancy:
60.73% 
 
Date/Time:
September 24, 2009   4:05pm - 4:35pm
 
Length:
48m 47s - 46 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Olatoyosi Odenike, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
U107 - Surgical Choices for Renal Cell Carcinoma that Optimize Long-Term Renal Function: Open or Laparoscopic? Partial or Complete Nephrectomy? 
Relevancy:
13.84% 
 
Date/Time:
September 24, 2009   4:35pm - 5:05pm
 
Length:
34m 23s - 67 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
William Huang, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM107 - Management of Iron Overload in Hematological Malignancies: Should We Chelate Patients with MDS? 
Relevancy:
79.26% 
 
Date/Time:
September 24, 2009   4:35pm - 5:05pm
 
Length:
20m 06s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Mikkael A. Sekeres, MD, MS (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
S103 - Current Best Practices in the Multidisciplinary Management of GIST 
Relevancy:
18.21% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
21m 57s - 52 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Robert G. Maki, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM108 - Therapy-Related Myeloid Neoplasms: The Price of Progress? 
Relevancy:
44.00% 
 
Date/Time:
September 24, 2009   5:10pm - 5:40pm
 
Length:
26m 24s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 25, 2009 - Friday
 
B201 - Neoadjuvant Therapy for Breast Cancer: Lessons Learned and New Directions with Targeted Therapeutics 
Relevancy:
27.26% 
 
Date/Time:
September 25, 2009   8:50am - 9:20am
 
Length:
25m 58s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Laura J. Esserman, MD, MBA (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM201 - Aggressive Lymphoma: Management in 2009 
Relevancy:
41.50% 
 
Date/Time:
September 25, 2009   8:50am - 9:20am
 
Length:
30m 44s - 50 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Jonathan W. Friedberg, MD, MMSC (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM202 - Indolent Lymphomas: Issues in Clinical Practice 
Relevancy:
63.93% 
 
Date/Time:
September 25, 2009   9:25am - 9:55am
 
Length:
28m 35s - 61 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Michael L. Grossbard, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY203 - Debate: All Patients at High Risk for Ovarian Cancer Should Undergo Routine Screening 
Relevancy:
17.72% 
 
Date/Time:
September 25, 2009   1:30pm - 2:00pm
 
Length:
41m 26s - 51 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Michael J. Birrer, MD, PhD (Speaker Disclosure)
 
Beth Y. Karlan, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM203 - Mantle Cell Lymphoma: How to Select the Best Treatment 
Relevancy:
50.69% 
 
Date/Time:
September 25, 2009   1:30pm - 2:00pm
 
Length:
26m 45s - 54 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Mitchell R. Smith, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON205 - Update on Wound Care for Cancer Patients 
Relevancy:
36.00% 
 
Date/Time:
September 25, 2009   2:40pm - 3:10pm
 
Length:
29m 26s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Robin Gemmill, MSN, RN, CNS (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM206 - How I Manage Relapsed NHL - What and When 
Relevancy:
50.90% 
 
Date/Time:
September 25, 2009   4:05pm - 4:35pm
 
Length:
29m 35s - 47 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
David G. Maloney, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GY207 - Debate: Therapy for the Patient with Platinum-Resistant/Refractory Recurrent Ovarian Carcinoma Should be Selected Based on the Results of an In Vitro Extreme Drug Sensitivity/Resistance Assay 
Relevancy:
13.40% 
 
Date/Time:
September 25, 2009   4:40pm - 5:10pm
 
Length:
25m 13s - 76 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Michael J. Birrer, MD, PhD (Speaker Disclosure)
 
Bradley J. Monk, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM207 - Debate: There is Still a Role for Observation in Follicular Lymphoma 
Relevancy:
73.10% 
 
Date/Time:
September 25, 2009   4:40pm - 5:10pm
 
Length:
36m 21s - 34 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Sandra J. Horning, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
ON207 - Sexuality and Cancer 
Relevancy:
21.45% 
 
Date/Time:
September 25, 2009   4:40pm - 5:10pm
 
Length:
34m 31s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Kate Tierney, RN, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
September 26, 2009 - Saturday
 
HM301 - CLL Treatment: Do Pre-treatment Characteristics Guide Current Treatment Choices? 
Relevancy:
62.76% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
22m 28s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Neil E. Kay, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC301 - Vitamin D 
Relevancy:
19.44% 
 
Date/Time:
September 26, 2009   8:15am - 8:45am
 
Length:
47m 47s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Joan M. Lappe, PhD, RN, FAAN (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM302 - CLL Treatment: What Happens after Relapse from Front-line Therapy? 
Relevancy:
47.21% 
 
Date/Time:
September 26, 2009   8:50am - 9:20am
 
Length:
25m 17s - 38 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Neil E. Kay, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI303 - Hepatocellular Carcinoma: New Trends and Contemporary Management 
Relevancy:
16.45% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
35m 09s - 59 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Andrew X. Zhu, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM303 - AML Therapy in the "Molecular Genetic" Era: How Does it Impact Therapeutic Approach? 
Relevancy:
81.01% 
 
Date/Time:
September 26, 2009   9:25am - 9:55am
 
Length:
40m 03s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Richard Stone, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
L304 - Current Status of Targeted Therapies in Lung Cancer 
Relevancy:
33.17% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 36s - 54 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Scott Gettinger, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
GI304 - Cytotoxic and Targeted Agents in Gastroesophageal Cancer 
Relevancy:
40.44% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
38m 40s - 62 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Manish P. Shah, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM304 - Treatment of AML in Older Adults: Where are We Going? 
Relevancy:
84.21% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
26m 50s - 48 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Mikkael A. Sekeres, MD, MS (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC304 - Cardiac Complications of Old and New "Targeted" Therapies 
Relevancy:
22.94% 
 
Date/Time:
September 26, 2009   1:30pm - 2:00pm
 
Length:
37m 00s - 36 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Anju Nohria, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM305 - Debate: Is Allogenic Stem Cell Transplant in First Remission the Optimal Therapy for All Adults with ALL? 
Relevancy:
80.62% 
 
Date/Time:
September 26, 2009   2:05pm - 3:10pm
 
Length:
46m 53s - 78 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speakers:
Jerald P. Radich, MD (Speaker Disclosure)
 
Wendy Stock, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
SC305 - Overview of New Developments in Patient Communication 
Relevancy:
14.19% 
 
Date/Time:
September 26, 2009   2:05pm - 2:35pm
 
Length:
28m 52s - 37 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Smith (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC306 - Management of the Obese Patient: A Growing Problem 
Relevancy:
28.32% 
 
Date/Time:
September 26, 2009   2:40pm - 3:10pm
 
Length:
37m 13s - 38 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Jennifer J. Griggs, MD, MPH (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L307 - Current Status in the Management of Stage IV NSCLC 
Relevancy:
22.51% 
 
Date/Time:
September 26, 2009   4:05pm - 4:35pm
 
Length:
42m 26s - 75 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Ronald B. Natale, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
rating
HM306 - Optimizing CML Therapy in 2009: Mission Accomplished? 
Relevancy:
44.99% 
 
Date/Time:
September 26, 2009   4:05pm - 4:35pm
 
Length:
36m 04s - 77 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Neil Shah, MD, PhD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
L308 - Personalized Targeted Therapy in Lung Cancer 
Relevancy:
13.98% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
55m 05s - 55 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Waun Ki Hong, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
HM307 - Treatment of APL in 2009: Cures Without Chemotherapy? 
Relevancy:
74.54% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
31m 20s - 49 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Farhad Ravandi-Kashani, MD (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
SC308 - New Developments in Anemia and White Cell Growth Factor Management 
Relevancy:
14.98% 
 
Date/Time:
September 26, 2009   4:40pm - 5:10pm
 
Length:
31m 47s - 41 Slides  
 
Total Credits:
0.50 CME/CE  
 
Speaker:
Thomas Smith (Speaker Disclosure)
 
Format:
     
  Synched Audio / Slides
 

 
40 Results Found, Showing 1 - 40